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Abstract
Background: Chronic bacterial infections occur as a result of the infecting pathogen’s ability to live within a biofilm,
hence escaping the detrimental effects of antibiotics and the immune defense system. Burkholderia pseudomallei, a
gram-negative facultative pathogen, is distinctive in its ability to survive within phagocytic and non-phagocytic cells, to
persist in vivo for many years and subsequently leading to relapse as well as the development of chronic disease. The
capacity to persist has been attributed to the pathogen’s ability to form biofilm. However, the underlying biology of
B. pseudomallei biofilm development remains unresolved.
Results: We utilised RNA-Sequencing to identify genes that contribute to B. pseudomallei biofilm phenotype.
Transcriptome analysis of a high and low biofilm producer identified 563 differentially regulated genes, implying that
expression of ~9.5 % of the total B. pseudomallei gene content was altered during biofilm formation. Genes involved in
surface-associated motility, surface composition and cell wall biogenesis were over-expressed and probably play a role
in the initial attachment of biofilms. Up-regulation of genes related to two component signal transduction systems
and a denitrification enzyme pathway suggest that the B. pseudomallei high biofilm producer is able to sense the
surrounding environmental conditions and regulate the production of extracellular polymeric substance matrix, a
hallmark of microbial biofilm formation.
Conclusions: The transcriptome profile described here provides the first comprehensive view of genes that contribute
to the biofilm phenotype in B. pseudomallei.
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Background
Bacterial cells have evolved a biofilm phenotype over
billions of years as part of their successful strategy to
colonize biotic and abiotic surfaces when faced with dif-
ferent environmental conditions. Biofilm consists of a
biological architecture of aggregated microbes on a sur-
face, enclosed within a mesh of exopolysaccharides, fatty
acids, DNA and large surface proteins [1]. Biofilms are
closely associated with persistence as the presence of the
extracellular matrix surrounding the cells renders the
bacteria less susceptible to anti-bacterial agents com-
pared to free-floating cells [2]. As a result, biofilm infec-
tions tend to be chronic and are difficult to eradicate.
The transition from free-swimming planktonic cells to
biofilm producers occurs in response to environmental
changes including pH, temperature, nutrient levels and
ionic strength. This response involves multiple regula-
tory networks which translate signals to alter the re-
organization of the bacterial cell to survive unfavourable
conditions [3]. It is generally believed that quorum
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sensing contributes to the formation of a functioning
biofilm. Human infections involving biofilm have been
described in patients with native valve endocarditis, cys-
tic fibrosis, periodontitis as well as chronic bacterial in-
fections such as prostatitis. Biofilm formation in medical
devices such as central venous and urinary catheters,
prosthetic heart valves, intrauterine devices and contact
lenses, is well described [4].
Burkholderia pseudomallei, the causative agent of me-
lioidosis, is known to produce biofilm. A major feature
of melioidosis is the difficulty in achieving complete bac-
terial eradication following an episode of infection and
an extended period of antimicrobial treatment is needed
for total clearance. Formation of biofilm has been pro-
posed as a contributory factor in the occurrence of
persistent infection in the host. Clinical response to anti-
microbials is slow and recurrent disease is common [5].
Sawasdidoln et al. [6] demonstrated that B. pseudomallei
isolates which were sensitive to doxycycline, ceftazidime,
imipenem and trimethoprim/sulfamethoxazole became
resistant under conditions that promoted the formation
of biofilm.
Levels of humoral antibodies in patients who have had
melioidosis remain high and seldom drop to basal level
even years after recovery from an acute infection, sup-
porting the notion of persistence [7]. It is possible that
B. pseudomallei can adapt to survival in vivo through
the formation of biofilm but the mechanism by which
this occurs in melioidosis patients is unclear [8]. It has
also been reported that B. pseudomallei biofilm does not
contribute to the virulence of the organism [9]. Based on
studies involving various B. pseudomallei mutants, acap-
sular mutants may or may not have reduced formation
of biofilm [6, 10]. On the other hand, restricted biofilm
formation was observed in the fliC flagella mutant [6]
and the polyphosphate kinase ppk mutant [11] whilst
the role of B. pseudomallei cyclic-di-GMP-phospho-
diesterase (CdpA) in biofilm formation and virulence
was established with the corresponding cdpA mutant
being attenuated in human macrophage cells [12]. A re-
cent report by Lazar-Adler et al. [13] proposed the role
of B. pseudomallei Trimeric Autotransporter Adhesins
(TAA) in biofilm formation whereby an insertional mu-
tant of the BPSS1439 gene was affected in its ability to
form biofilm in addition to being partially attenuated in
an acute murine melioidosis model, implying a positive
relationship between biofilm formation and bacterial
virulence.
A number of studies involving individual mutants of
the biofilm-associated genes described above have dem-
onstrated that inactivating these single genes does not
completely attenuate biofilm formation. This suggests a
more global regulation of multiple B. pseudomallei genes
and pathways involved in biofilm formation and may,
either directly or indirectly, be related to virulence or
persistence in infected hosts. Hence, in this study, a
comprehensive transcriptional analysis of representative
high and low clinical B. pseudomallei biofilm producers
was performed to identify the genes required for biofilm
formation in B. pseudomallei. In addition, preliminary
virulence studies of these two B. pseudomallei biofilm
producers were carried out using the nematode Caenor-
habditis elegans and BALB/c mice infection models.
Results
Transcriptome analysis and global transcriptional profile
of B. pseudomallei biofilm strains
The sequence based transcriptome approach has been
used to study regulatory mechanisms and pathogenicity
factors of Pseudomonas syringae [14], Mycobacterium
tuberculosis [15], Pseudomonas aeruginosa [16], Listeria
monocytogenes and Listeria innocua [17]. We utilised
RNA sequencing and comparative transcriptome ana-
lysis to identify genes and their respective expression
levels that contribute to the B. pseudomallei biofilm
phenotype. A total of 84 B. pseudomallei clinical isolates
were analysed for biofilm formation (Additional file 1).
From this collection, we selected one representative
from the high biofilm producers, UM6, and one of the
low biofilm producers, UM1 for RNA-Seq analysis. The
biofilm formation phenotypes of both these strains is
presented in Fig. 1. Both strains were sequenced on the
Illumina platform and sequence reads were mapped to
the annotated B. pseudomallei strain K96243 genome.
The expression analysis demonstrated that appro-
ximately 84.5 % of the UM1 and UM6 reads mapping
to B. pseudomallei K96243 genes had a calculable
‘fragments per kilobase of million fragments mapped’
(FPKM) value (Additional file 2). The pattern of relative
gene expression was similar between the biological re-
plicates with a correlation coefficient of r = 0.86 and
r = 0.87 for UM6 and UM1, respectively.
We next used the transcriptome data to identify genes
that potentially contribute towards the biofilm pheno-
type in B. pseudomallei as determined by differential
transcription analysis between UM6 and UM1. By adopt-
ing a q-value of ≤ 0.05 and log2 fold-change above 1 to
classify a transcript as being differentially expressed,
transcriptional analysis revealed 563 differentially ex-
pressed genes (324 up-regulated genes and 239 down-
regulated genes) in UM6 relative to UM1. Functional
classification of up- and down-regulated genes showed
that most of these genes encode core functions such as
cell envelope, central intermediary metabolism, energy
metabolism, transport, regulatory proteins and cellular
processes (Additional file 3). Many genes encoding pro-
teins with unknown function or hypothetical proteins
were also modulated in the high biofilm producer, UM6
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(Additional file 3). Furthermore, genes predicted to en-
code proteins that are known to localise as extracellular
proteins were observed at a higher percentage in the
group of genes with up-regulated expression (Additional
file 3). Eleven genes were randomly selected from seven
functional categories (Fig. 2a and Additional file 4) for
validation by quantitative real-time PCR (qRT-PCR).
The expression was verified by qRT-PCR as up- or
down-regulated, albeit with magnitudes different from
those recorded by RNA-Seq (Fig. 2b and Additional file 5).
In lieu of the large number of significantly differentiated
genes, only data related to genes that have some func-
tional information are shown and discussed below.
Fimbriae and pilus may be required for initiation of
B. pseudomallei biofilm attachment
Motility influences biofilm formation in various pathogens
including Enteropathogenic E. coli [18, 19] and P. aerugi-
nosa [20, 21]. A number of fimbriae and pilus-related genes
(BPSL1799, BPSL1888, BPSL1893, BPSL2027, BPSL2028,
BPSS0092, BPSS1597, BPSS1600 and BPSS1768) were
significantly up-regulated in UM6 (Figs. 2a and 3 and
Additional file 4) suggesting that these structures may also
be important in B. pseudomallei biofilm attachment. To
validate the observation of over-expressed pili-related
genes, we performed scanning electron microscopy (SEM)
on both strains. The micrographs (Fig. 4) demonstrate the
Fig. 1 B. pseudomallei biofilm formation phenotypes. a Biofilm formation was measured by crystal violet staining assay using static broth cultures
of B. pseudomallei UM1 (low producer) and UM6 (high producer) in a 96-well flat-bottomed microtiter plate and in test tubes. Non-pathogenic
B. thailandensis ATCC 700388 was used as the reference strain in this study. b Colony morphology of B. thailandensis ATCC 700388, B. pseudomallei
UM1 (low producer) and UM6 (high producer) on Ashdown agar plates after 48 h incubation at 37 °C
Chin et al. BMC Genomics  (2015) 16:471 Page 3 of 15
presence of pili protruding from UM6 which are not ob-
served in UM1, thus supporting the transcriptional-level
analysis (Fig. 4).
To gain more insight into the identified genes, we used
the Conserved Domain Database (CDD) to look at protein
domains of these genes. BPSL2027 (putative fimbriae-
related protein) contains an usher superfamily domain
(pfam0057) and PapC C-terminal (pfam13953) and N-
terminal conserved domains (pfam13954). Concomitantly,
two outer membrane usher proteins, BPSS0093 (4.07 fold)
Fig. 2 B. pseudomallei biofilm development transcriptome profile. a Expression profiles of modulated-genes according to functional categories.
Transcript expression of log2 fold level are depicted by the histogram. The height of the bars correspond to the degree of expression level. Red
and green bars represent up-and down-regulation in relative expression levels, respectively. b qRT-PCR analysis of eleven B. pseudomallei genes
from seven functional categories differentially expressed as determined by RNA-Seq. The results are from a representative of three reproducible
independent experiments
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and BPSL1800 (5.99 fold), were over expressed in UM6
and may be involved in assembly of pre-pilins for fimbriae
biogenesis. In contrast, a cohort of flagella-related genes
encoding the flagella basal body, motor switch and hook
proteins (BPSL0026, BPSL0027, BPSL0030, BPSL0226,
BPSL0230, BPSL0232, BPSL0270, BPSL0271, BPSL0281,
BPSL3310 and BPSL3311) were down-regulated in UM6
(Figs. 2a and 3 and Additional file 4), similar to that
previously described for Pseudomonas aeruginosa [22]
and Escherichia coli biofilm formation [22]. The down-
regulation of flagella-related genes was validated with mo-
tility assays performed on solid agar, which demonstrated
that the UM6 strain has reduced swimming and swarming
motility compared to the UM1 strain (Table 1).
Over expression of extracellular polymeric substance
(EPS) matrix components for development of
B. pseudomallei biofilm architecture
Genes encoding for polysaccharides (BPSL0603, BPSL0605,
BPSL0618, BPSL0619, BPSL0620, BPSS1649) and EPS
Fig. 3 Alteration of surface composition and regulation of anaerobic respiration contribute to B. pseudomallei biofilm phenotype. Transcript expression
of log2 fold level are depicted by the histogram in the inner-most ring of the circular maps. The height of the bars correspond to the degree of
expression level. Genes uniquely expressed in UM6 and UM1 are coloured in dark red and dark green, respectively. Red and green bars represent
up- and down-regulation in relative expression levels, respectively. Hierarchical clustering of B. pseudomallei UM1 (low biofim producer) and UM6 (high
biofilm producer) expression profiles according to functional categories. The heat maps indicate the gene transcripts expressed as FPKM. Genes whose
expression did not change are coloured in black
Fig. 4 Scanning electron microscope micrograph of biofilm formation by B. pseudomallei on a glass slide. B. pseudomallei UM1demonstrated
reduced biofilm formation compared to UM6. a Extracellular polymeric substance (EPS) is clearly visible around the B. pseudomallei UM6 colonies.
b The matrix is holding the bacteria together but has not yet been encapsulated. c Pilus protruding from a UM6 colony
Chin et al. BMC Genomics  (2015) 16:471 Page 5 of 15
(BPSS1978) were over-expressed in UM6 (Fig. 2a and
Additional file 4). Observations based on SEM micro-
graphs support the expression profile whereby the pre-
sence of EPS matrix encapsulating the bacteria was only
seen in the high biofilm producer strain UM6 but not in
the low biofilm producer strain UM1 (Fig. 4). Attachment
of Gram-negative bacteria to a surface via outer membrane
proteins is the first step in biofilm formation, followed by
replication to form micro colonies and production of a ma-
ture biofilm [23]. Several outer membrane and cell-surface
encoded proteins were also over-expressed in UM6,
including BPSS0908, BPSS0909, BPSS1287, BPSS1487,
BPSS1742, BPSS1434, BPSS1439, BPSS2053, BPSL1552
and BPSL3094 (Figs. 2 and 3 and Additional file 4).
Alteration of B. pseudomallei surface composition in a
high biofilm producer
Expression levels of 13 fatty acid biosynthesis-related genes
(BPSL0608, BPSL0618, BPSL2382, BPSS0302, BPSS0306,
BPSS0311, BPSS0481, BPSS0483, BPSS0484, BPSS0486,
BPSS0712, BPSS1285 and BPSS2328), seven phospholi-
pases and lipase-related genes (BPSL1064, BPSS0016,
BPSS1740, BPSS1741, BPSS1937, BPSS2279 and BPS
S2319) as well as seven cell envelope biogenesis-related
genes (BPSL0607, BPSL1872, BPSL3094, BPSL3312, BPS
S1840, BPSS1932 and BPSS2016) were up-regulated in the
high biofilm producer (Figs. 2 and 3 and Additional file 4).
Furthermore, 13 lipoprotein-encoding genes (BPSL0092,
BPSL0303, BPSL1233, BPSL1445, BPSL1927, BPSL1957,
BPSL2026, BPSL2043, BPSL2359, BPSL2705, BPSS1847,
BPSS1924 and BPSS1929) were also over-expressed in
UM6. One of the putative lipoproteins (BPSL2026) con-
tained a spore coat protein U domain, SCPU (cl02253),
which is generally present in the bacterial family of se-
creted pili proteins involved in motility and biofilm for-
mation. Concomitantly, three putative SCPU domain
containing export protein genes, BPSL1009 (1.95 fold),
BPSL2030 (4.01 fold) and BPSL2031 (3.51 fold), were also
identified as over-expressed in UM6 (Fig. 3 and Additional
file 4).
LuxR-like domain is likely to be involved in
B. pseudomallei biofilm formation
Quorum sensing (QS) is a form of cell to cell communi-
cation that bacteria adopt to coordinate group behaviour
in a cell density dependent manner. QS relies on N-acyl
homoserine lactones (AHLs) to regulate gene expression
in response to cell density dependent cues and is related
to biofilm formation and exopolysaccharide production
[1, 20, 24]. In addition, QS influences the expression
profile of diverse genes including antibiotic tolerance
and virulence determinants [2]. The QS system plays a
major role in the control of bacterial biofilm formation in
many known pathogens including P. aeruginosa [20, 25],
Streptococcus pneumoniae [26] and E. coli [27, 28].
In this study, the expression levels of homoserine
O-acetyltransferase (BPSL0197) and the LuxR-family
transcriptional regulator (BPSS0312), which, together
mediate gene expression following association with the
cognate AHL (s), were up-regulated in UM6 (Fig. 2a
and Additional file 4).
Up-regulation of two component signal transduction
systems and stress proteins in the B. pseudomallei high
biofilm producer
The two component signal (TCS) transduction system
related proteins, a sensor histidine kinase protein and
response regulator, are responsible in regulating biofilm for-
mation in a number of bacteria. Several genes related to the
two-component signal transduction systems (BPSL0106,
BPSL1633, BPSL1634, BPSL2025, BPSL2314, BPSS0124,
BPSS0664 and BPSS1162) were up-regulated in UM6
(Fig. 2a and Additional file 4). Interestingly, two putative
sensor kinases (BPSL2025 and BPSL1634) demonstrated
considerable similarity to the E. coli RcsC sensor protein,
particularly at the conserved domains (Additional file 6).
Four genes encoding response regulators (BPSL1633,
BPSL2314, BPSS0124 and BPSS1214) that contained
a LuxR-like domain (cd06170) were identified as up-
regulated in UM6 (Fig. 2a and Additional file 4). Amongst
the identified genes, a hypothetical protein (BPSL0106)
containing the CpxP component domain (cl01482), was
up-regulated by 4.1 fold. Proteins containing the Cpx com-
ponent domain are known modulators of cell-envelope
stress in Gram-negative bacteria including E. coli biofilm-
producing cells [29]. In addition, genes encoding two
universal stress proteins (BPSS1140, BPSS1934) and one
hypothetical protein (BPSS0837) with a universal stress
protein family domain (cd00293) as well as genes of
three stress–related proteins (BPSS2250, BPSL1484 and
BPSL1406) were also up-regulated in UM6.
Modulation of the denitrification enzyme pathway in the
B. pseudomallei high biofilm producer
Two anaerobic-related genes (BPSL2309 and BPSL2356),
three reductase genes involved in nitrate metabolism
(BPSL2351, BPSL1607, BPSS1487) and several genes en-
coding fumarate and the nitrate reduction (FNR) sub-
family were over expressed in UM6 (Figs. 2a and 3 and
Additional file 4). The majority of these genes encode for
proteins involved in nitrate regulation and dissimilation
Table 1 Swimming and swarming analysis of UM1 and UM6.
Data are mean ± SD of two independent experiments
Phenotype UM1 UM6
Swimming (mm in diameter) 69.55 ± 7.14* 53.4 ± 1.98
Swarming (mm in diameter) 74.55 ± 3.62* 55.82 ± 2.36
*p < 0.05 (Students’ t test)
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including nitrate reductases (BPSL2309, BPSL2310,
BPSL2311), nitrate-oxide reductase (BPSL1607), nitrate
sensor protein (BPSL2313) and nitrate extrusion proteins
(BPSL2307, BPSL2308) (Fig. 3 and Additional file 4). Of
interest, two nitrite extrusion proteins and a transport-
related membrane protein (BPSS2206) contain the major
facilitator superfamily (MFS) domain (cd06174), which is
involved in the symport, antiport or uniport pumping of
various substrates such as sugars, oligosaccharides and
antibiotics [30]. Moreover, one of the crp-family trans-
criptional regulators (BPSS1917) contained the effector do-
main of the CAP family transcription factor (cd00038)
whilst two hypothetical proteins (BPSL0616 and BPSL0617)
that also contained the same domain, were up regulated
(4.72 fold and 4.74 fold, respectively) in UM6 compared to
UM1. Up-regulation of MFS-containing genes has re-
cently been associated with the development of biofilm by
P. aeruginosa [31] as well as adherence and biofilm forma-
tion for Acinetobacter baumannii [30].
Potential correlation between B. pseudomallei biofilm
formation and virulence in nematode and mice models
Biofilm formation has been implicated as a virulence fac-
tor in C. elegans infection models for Yersinia pseudotu-
berculosis [32] and staphylococcal infections [33]. Hence,
we used the C. elegans host model to evaluate virulence
of the different B. pseudomallei biofilm producers and
determine the contribution of biofilm in B. pseudomallei-
mediated killing of C. elegans. Nematodes were fed with
B. pseudomallei UM1 (low biofilm producer) and UM6
(high producer), respectively, and the non-pathogenic B.
thailandensis ATCC 700388 [34]. As shown in Fig. 5a,
worms exposed to the laboratory food source E. coli OP50
remained completely viable over the course of the expe-
riment. Worms exposed to UM6 died significantly faster
(Logrank (Mantel-Cox) test p < 0.0001) with a mean time
to death (TDmean) of 13.897 ± 0.401 h compared to worms
exposed to B. thailandensis (TDmean = 77.631 ± 1.638 h)
and UM1 (TDmean = 77.876 ± 1.183 h). The preliminary
Fig. 5 B. pseudomallei biofilm may contribute to bacterial pathogenesis. a B. pseudomallei biofilm contributes towards lethality in C. elegans. One-day
old Glp worms were transferred to individual B. pseudomallei isolates UM1 (black line, solid triangles), UM6 (black line, solid circles), B. thailandensis ATCC
700388 (black line, open squares) and E. coli OP50 (black dashed line, open squares). The graph shows the mean ± SD of three replicates (30 worms/
replicate) from a representative of two independent experiments. b Mice (n = 5) were challenged intraperitonealy with a lethal dose of B. pseudomallei
UM6 (circle) or UM1 (triangle) and their survival was monitored. Mice challenged with UM6 succumbed to disease significantly faster (within 24 h) than
those challenged with UM1 [Logrank (Mantel-Cox) test, p-value = 0.0084]. c The bacterial loads in the spleen, liver and lung of B. pseudomallei-infected
mice are shown. Each symbol represents one mouse. The horizontal line indicates the geometry mean for each group. Significance was determined
using the Mann–Whitney test (*p < 0.05). Representative colony morphologies of B. pseudomallei UM1 and UM6 harvested from the infected mice
organs are shown. d B. pseudomallei UM6 attenuates production of various cytokines. Lungs of BALB/c mice challenged with B. pseudomallei UM1 or
UM6 were harvested and the levels of 12 pro- and anti-inflammatory cytokines were measured by the mouse cytokine Multi-Analyte ELISArray Kit
(Qiagen). Cytokine expression is shown as fold increase compared to the control unchallenged mice
Chin et al. BMC Genomics  (2015) 16:471 Page 7 of 15
survival/virulence assay demonstrates that B. pseudomallei
biofilm production could be a contributing virulence fac-
tor in the pathogenesis of this bacterium.
BALB/c mice serve as a well-established animal model
for melioidosis. To confirm the findings in C. elegans,
mice were challenged intraperitoneally with a lethal dose
of UM6 or UM1 and mice survival was monitored. As
observed in C. elegans, mice infected with UM6 died sig-
nificantly faster than those infected with UM1 (Fig. 5b).
All mice infected with UM6 succumbed to disease
within 24 h with a median survival of 1 day while only 1
mouse infected with UM1 died on day one and the
remaining 4 mice succumbed to disease on day 3 with a
median survival of 3 days. Although UM6 appeared to
be more virulent, bacterial loads in the lungs and livers
of UM6 and UM1-infected mice were similar, and the
spleens of UM6 infected mice displayed a significantly
lower bacterial count compared to UM1 infected mice
(Fig. 5c).
The high biofilm producer was able to kill both mice
and nematode relatively quickly suggesting an imbalance
between the host proinflammatory and anti-inflammatory
responses towards infection. Hence, we asked if the
presence of the biofilm deregulated this equilibrium by
limiting the cytokine response to infection. To address this
question, the mouse cytokine Multi-Analyte ELISArray
Kit (Qiagen) was utilised to simultaneously measure 12
cytokines i.e., IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12,
IL-17A, Interferon-γ (IFN-γ), Tumour necrosis factor-α
(TNF-α), Granulocyte- Colony Stimulating Factor (G-CSF)
and Granulocyte-Macrophage Colony Stimulating Factor
(GM-CSF). We observed a significant attenuation in the
levels of all 12 cytokines within the lungs of mice infected
with UM6 compared to lungs from mice infected with
UM1 (Fig. 5d). In summary, we propose that high levels of
biofilm production attenuate the cytokine response which
may explain the increased virulence of B. pseudomallei
UM6.
A similar gene expression profile is observed in other
B. pseudomallei high and low biofilm producing strains
The transcriptional data presented here have identified
genes that most likely contribute towards the biofilm
phenotype in B. pseudomallei. To confirm that the ob-
served gene expression pattern is not restricted to UM6
and UM1, we selected a second high biofilm producing
strain (UM5) as well as a low B. pseudomallei biofilm
producing strain, UM2 (Fig. 6a) to analyse the expres-
sion profile. Seven of 11 genes that were modulated in
UM6 (Fig. 2b) were analysed, including genes associated
with the denitrification pathway, cell envelope and EPS
production. Six of the selected genes were also over-
expressed in UM5 compared to UM2 (Fig. 6b). Both iso-
lates were also analysed in C. elegans (Fig. 6c) and mice
(Fig. 6d) infection assays and we observed that the high
biofilm B. pseudomallei strain UM5 contributed to
higher killing kinetics in both animal models.
Discussion
B. pseudomallei biofilm formation may contribute to
intracellular survival, dormancy and antibiotic resistance
[35] but the mechanism by which this occurs in humans
is yet to be demonstrated [8]. To date, only a handful of
B. pseudomallei biofilm-associated genes have been
studied and have mainly focused on single-gene pheno-
types. In this study, we demonstrate that biofilm produc-
tion is a complex process that involves the differential
expression of several genes. RNA sequencing analysis
performed on low and high biofilm-producing B. pseudo-
mallei strains identified genes that contribute to biofilm
formation. We identified 563 differentially expressed
genes during the formation and growth of biofilm, ac-
counting for about 9.5 % of the total B. pseudomallei gene
content. The transciptome analysis of biofilm related
genes was performed on mid-log bacterial cultures, the
pre-biofilm state, to conform to standard sequencing pro-
tocols. Keeping in mind that our analysis may not neces-
sarily reflect a true biofilm environment, we subsequently
analysed a subset of genes from 7 representative func-
tional groups on UM1 and UM6 cells grown to the sta-
tionary phase (mature biofilm state). qRT-PCR analysis
demonstrated comparable magnitudes and patterns of
gene expression between RNA samples extracted from
cells at different growth phases (data not shown). Thus, our
findings offer new insights into the different transcriptional
landscapes observed between clinical B. pseudomallei high
and low biofilm producing isolates.
Biofilm producing pathogens sense environmental sig-
nals via the TCS transduction system and adapt to these
changes by transcribing genes that planktonic organisms
do not [21, 36]. Based on the expression profile of the
high biofilm producer, we hypothesise that B. pseudo-
mallei also responds to varied environmental signals, for
instance pH, temperature, osmotic pressure and oxygen
concentration via activation of various TCS (Fig. 7).
Upon encountering the environmental cues that stress
the cell membranes, B. pseudomallei most likely acti-
vates the RcsB-RcsC TCS and subsequently regulates
genes that encode proteins involved in the alteration of
surface components, including capsular polysaccharides,
cell envelop biogenesis, lipoproteins, phospolipases and
fatty acid biosynthesis that are pivotal for survival of B.
pseudomallei within the host (Figs. 2a and 7). RcsC
sensor kinase is required for biofilm formation in E. coli
and regulates genes encoding for proteins that are either
localised to the envelope or have activities that affect the
structure/properties of the bacterial surface [21, 36]. In
addition, the cell-to-cell communication small fatty acid
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signal molecule, diffusible signal factor (DSF), regulates
the expression of factors contributing to virulence, anti-
biotic tolerance and biofilm formation [37, 38]. DSF is
synthesized by putative enoyl-CoA hydratase and puta-
tive acyl-coA ligase in Xanthomonas campestris and
Burkholderia cecocepacia [39–41]. Three fatty acid bio-
synthesis genes that encode for Co-A hydratase and ligase
are up-regulated in UM6. This, in turn, most likely regu-
lates EPS-associated genes, the core component for main-
tenance of biofilm architecture and pilus biogenesis-related
genes to initiate the attachment of planktonic cells for
microcolony formation.
During the growth of micro colonies, methyl- accept-
ing chemotaxis protein MCP (BPSL2367), a sensor pro-
tein in TCS, is up-regulated in UM6 and subsequently
suppresses the regulation of CheB which is responsible
for flagella switch (Fig. 7). Down regulation of the
flagella biosynthesis cascade seen in the high biofilm
producer (Figs. 2a and 3) suggests sessile transition of
motile B. pseudomallei for biofilm development [28].
Bacterial biofilm formation is known to affect colony
morphotype (mucoid vs non-mucoid) [20] and bacterial
attachment [42]. This is also true for B. pseudomallei
biofilm, whereby the low biofilm producer UM1 that ex-
hibits a mucoid colony morphotype, has lower expres-
sion levels of pilus, fimbriae, lipoprotein, polysaccharide
and EPS-related genes when compared to the wrinkled
colony morphotype observed in UM6 (Fig. 1). This
observation is similar to a P. aeruginosa mutant with
a wrinkled colony phenotype capable of forming pro-
nounced pellicles that exhibited increased production of
exopolysaccharide and EPS [20].
Recently, the CRP/FNR superfamily protein Bcam1349
of Burkholderia cenocepacia (Bcc) was reported as a cyc-
lic diguanosine monophosphate (c-di-GMP) effector in
regulating biofilm formation and is involved in virulence
[43]. This protein regulates the increased production of
cellulose and fimbriae [43]. Two hypothetical proteins
(BPSL0616 and BPSL0617) with the CRP/FNR super-
family conserved domain were significantly up-regulated
in UM6 (Fig. 2a and Additional file 4). Protein sequence
analysis revealed that BPSL0617 has 69 % identity to
Bcam1349, suggesting that it is the ortholog of the Bcc
Bcam1349 (Additional file 7). Of note, the neighboring
Fig. 6 The B. pseudomallei high biofilm producer, UM5, also results in faster killing kinetics and over-expression of biofilm-associated genes compared
to a second low biofilm producing isolate, UM2. a Biofilm index of UM2 and UM5. b qRT-PCR analysis of B. pseudomallei genes from seven functional
categories differentially expressed by RNA-Seq analysis. The results are from a representative of three reproducible independent experiments. c Killing
assay of C. elegans infected with UM2 (black line, closed square), UM5 (black line, closed triangle) and B. thailandensis (black line, open square). The
graph shows the mean ± SD of three replicates (30 worms/replicate) from a representative of two independent experiments. d Mice (n = 5) were
challenged intraperitonealy with a lethal dose of B. pseudomallei UM5 (triangle) or UM2 (square) and their survival was monitored. Mice challenged
with UM5 succumbed to disease significantly faster (within 24 h) than those challenged with UM2 [Logrank (Mantel-Cox) test, p-value = 0.0084]
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genes of these two hypothetical proteins were also up-
regulated and a number of these genes are involved in
surface protein modification (Additional files 4 and 8).
Another member of the CRP/FNR family protein, the
c-di-GMP response regulator ClpB heat-shock protein
(BPSL1484) is also up-regulated in UM6. Furthermore,
a cohort of fimbriae related genes, including three
chaperone-usher gene clusters (BPSL1799–BPSL1801;
BPSL2026–BPSL2028; BPSS0091–BPSS0093) which make
up the chaperone-usher fimbriae pathway (CUP) were
also over expressed in UM6 (Additional files 4 and 7). Up-
regulation of fimbriae genes in biofilm formation seen in
this study are similar to that in Klebsiella pneumoniae
[44] and E. coli [45] which promotes adhesion to abiotic
surfaces. In addition, P. aeruginosa fimbrial CupE/Csu
proteins that contain the SCPU sub-domain are reportedly
involved in structuring of biofilm [46]. Concomitantly,
three hypothetical proteins with the conserved SCPU do-
main (BPSL1009, BPSL2030 and BPSL2031) up-regulated
in the high biofilm producer may likely play a role in B.
pseudomallei biofilm formation.
As the micro colonies mature into a progressively thick
biofilm, a nutrient and oxygen-limited environment forms
[21, 25] and the anaerobic fitness of the pathogen is pivotal
for survival in the biofilm [47]. P. aeruginosa uses nitrate as
an alternate electron acceptor through a denitrification
enzyme pathway during the anaerobic growth of biofilm
[48, 49] and this is regulated by ANR, an ortholog of the
E. coli FNR [48, 49]. This transcriptional profiling suggests
that the high B. pseudomallei biofilm producer may sense
oxygen limitation through the NarX/NarL TCS and subse-
quently activate the nitrate reductase operon (BPSL2307–
Fig. 7 Summary of B. pseudomallei genes that contribute to biofilm development. a In response to varied environmental signals, B. pseudomallei
regulates the two-component signal (TCS) transduction system to adapt to environmental changes, by (b) transcribing genes that encode proteins
involved in the alteration of surface components and components crucial to initiate attachment of planktonic bacterial cells to solid surfaces for
microcolony formation. As the biofilm grows, an oxygen-limited environment forms. c The high biofilm producing B. pseudomallei strain utilises nitrate
for anaerobic growth through the denitrification enzyme pathway. Arrow represents activator connection; solid lines represent direct activation; dashed
lines represent indirect activation. The boxes and fonts highlighted in red depict the up-regulated biological processes and genes, respectively, while
the box highlighted in green depicts the down-regulated biological processes
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BPSL2314) and several types of nitrate reductases. This
suggests that the facultative anaerobe B. pseudomallei is
also likely to utilise nitrate for anaerobic growth in biofilm
through the denitrification pathway regulated by BPSL0617
(Fig. 7). To our knowledge, this is the first report that
describes the involvement of the TCS and denitrification
enzyme pathways within the anaerobic environment in B.
pseudomallei biofilm development.
Biofilm formation in other pathogenic bacteria such as
Staphylococcus aureus and Streptococcus pneumoniae has
been reported to be associated with altered host immune
responses [50, 51]. Our preliminary study suggests that
B. pseudomallei biofilm is probably a contributing factor
towards virulence in both C. elegans and BALB/c mice
models (Fig. 5a and b). Furthermore, UM6, the high biofilm
producer strain failed to elicit the expected cytokine
response even though the number of recoverable CFU was
similar for the two strains (Fig. 5d). Many inflammatory
cytokines referred to as the “core host immune response”
molecules commonly seen in general inflammation infec-
tions including melioidosis [52], were not over expressed in
UM6 infected-mice. This attenuation of in vivo inflamma-
tion suggests that intracellular B. pseudomallei are camou-
flaged from the host immune defense response by the
biofilm causing the host to succumb to the infection.
Although our findings challenge the previous report by
Taiweechaisupapong et al. [9], both studies are limited by
the small number (n = 2) of isolates to conclude a positive
or negative association between B. pseudomallei biofilm
formation and virulence and the analysis of a larger B.
pseudomallei strain cohort should be undertaken.
Conclusions
In summary, this is the first report of the complete
transcriptome profile of a B. pseudomallei biofilm pro-
ducer. We have identified genes that are likely involved
in the development of the B. pseudomallei biofilm phe-
notype, including quorum sensing, motility and surface
composition-related genes (Fig. 2a). Interestingly, many
of these genes are clustered together in the genome and
may be regulated as an operon (Additional file 8). We
postulate that the ability to sense various environmental
cues and adapt to anaerobic conditions via the denitri-
fication enzyme pathway is pivotal for the formation of
B. pseudomallei biofilm in the infected host which sub-
sequently allows for persistent infection in chronic meli-
oidosis. B. pseudomallei is particularly recalcitrant to
antibiotic treatment and this is most likely attributable
to biofilm formation. Thus, novel strategies designed to
thwart B. pseudomallei biofilm formation or to block a
specific biofilm developmental stage, such as the use of
anti-adhesion agents and inhibitors which interfere with
signal transduction, are exciting avenues for the develop-
ment of potent and bioavailable treatment strategies.
Methods
Bacteria
The four clinical B. pseudomallei isolates (UM1, UM2,
UM5 and UM6) as well as two reference strains, B.
thailandensis ATCC 700388 [53], and B. pseudomallei
K96243 [54] used in this study are listed in Additional
file 9.
Sample cultivation, RNA isolation and sequencing
Overnight cultures of B. pseudomallei (K96243, UM1
and UM6) were diluted 1:100 in 50 mL BHI broth and
were grown at 37 °C until mid- logarithmic phase
(OD600 = 0.5). Total RNA was isolated from two bio-
logical replicates of B. pseudomallei UM6 and UM1 har-
vested at mid- logarithmic growth phase using TRIzol
(Invitrogen Life Technologies, CA, USA) according to
the manufacturer’s instructions. Residual DNA was com-
pletely removed using QIAGEN’s RNase-Free DNase Set
and complete DNA removal was validated by performing
PCR with the B. pseudomallei recA gene primers. The
integrity of the total RNA was assessed on the Agilent
2100 Bioanalyzer. Total RNA (10 μg) was subjected
to 23 s and 16 s ribosomal RNA removal using the
MicrobExpress kit (Ambion, CA, USA). Ribosomal de-
pleted RNA was resuspended in 5 μL elution buffer
(Qiagen, GmbH, Germany). A total of 15.5 μL Elute
Prime Fragment Mix from the (non-stranded) TruSeq
RNA Sample Prep kit (Illumina, CA, USA) was mixed
with 4 μL of ribosomal depleted RNA and used for RNA
fragmentation followed by cDNA synthesis, end-repair,
TruSeq indexed-adapter ligation and PCR enrichment
as per the TruSeq RNA sample preparation protocol
(Illumina, CA, USA). A total of 6 libraries (2 biological
replicates of each bacterial sample), each labelled with a
unique index, were multiplexed in one flow cell lane and
the sequencing run was performed on the Illumina
HiSeq2000 sequencing platform.
Mapping and analysis of Illumina reads
Sequence reads from each sample were quality pre-
processed using the FASTX-toolkit fastq_quality_filter.
Trimming was based on the minimum accepted lllumina
quality value of 20 and minimum accepted read size of
30 bp. The pre-processed reads were separated between
paired and orphan reads using the Python script. Only
the paired reads were used in the analysis while orphan
reads were discarded. After pre-processing, an average
of 7.5 million reads, corresponding to 95 % of the total
reads, were mapped to chromosomes 1 and 2 of the B.
pseudomallei strain K96243 genome sequence (GenBank
Accession numbers NC006350 and NC006351). Due to
the absence of genome sequences for both UM1 and
UM6, this approach may be biased against the accessory
genome of B. pseudomallei, however, transcripts that
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mapped to the core genes were the main interest of this
study. Mapping generating four total transcriptome pro-
files (Additional file 2) using the alignment tool TopHat
version 2.02 [55] integrated with Bowtie version 0.12.7
[56]. The TopHat default settings were used: 20 align-
ments per read were allowed with up to 1 mismatch per
alignment. To determine differential expression of known
transcripts, the resulting aligned reads were analysed by
Cuffdiff, a part of the Cufflinks package version 2.02 [55]
and expression of those transcripts was reported as frag-
ments per kilobase of transcript per million mapped reads
(FPKM). Overall, ≥ 87 % of the generated transcriptome
reads were mapped to the B. pseudomallei K96243 refe-
rence genome. Transcripts with a q-value of ≤ 0.05 and
log2 fold-change above 1 were considered as differentially
expressed transcripts. Sequence reads were deposited in
the database of the European Nucleotide Archive with
accession number PRJEB6085 and are accessible via
http://www.ebi.ac.uk/ena/data/view/PRJEB6085. The sam-
ple accession numbers are ERR475457 (UM1;1st replicate),
ERR475458 (UM1; 2nd replicate), ERR475459 (UM6;1st
replicate) and ERR475460 (UM6; 2nd replicate).
Hierarchical clustering
Selected data were organized by a hierarchical clustering
with the web-based software Cluster 3.0. The clustering
algorithm is based on an uncentered correlation metric,
with average linkage clustering and visualized using Java
Treeview V1.1.3. [52]
PSORT
The cellular localization of each differentially expressed
gene was predicted using PSORTb version 3.0.2 (http://
www.psort.org/psortb/). For the run, the following pa-
rameters were used: Organism type: Bacteria; Gram
stain: Negative. BPSLt38 was excluded from the analysis
as it is a tRNA.
Gene ontology
Functional classifications were carried out based on
Comprehensive Microbial Resources (CMR) annotations
(www.cmr.jcvi.org) as previously described by Chieng
et al. [57].
Quantitative real-time PCR (qRT-PCR)
qRT-PCRs were performed with total DNase-treated
RNA on the Bio-RadiCycler (BioRad Laboratories, USA)
to quantify the expression of eleven genes from seven
functional categories. Briefly, 20 μL reactions were per-
formed using the iScript™ One-Step RT-PCR kit with
SYBR Green according to the manufacturer’s instruc-
tions (BioRad Laboratories, USA), primers at a final con-
centration of 1 μM and a data acquisition temperature
of 76 °C. In order to control for variation in RNA
concentration, cycle threshold (Ct) values were normal-
ized to B. pseudomallei 16 s rRNA that does not change
with infection [58]. Primer sets used in this study are
shown in Additional file 10.
Scanning electron microscopy analysis of biofilm
formation
Bacteria were cultured as previously described [34].
Briefly, overnight cultures of B. pseudomallei (UM1 and
UM6) were diluted 1:100 into 50 mL of fresh BHI broth
and grown overnight in a shaking incubator at 37 °C. At
the end of the incubation, the bacterial density was ad-
justed to OD600 = 1 using a spectrophotometer. For each
isolate, 2 mL of bacterial suspension was added to a 12-
well plate with 10 mm × 10 mm glass slides placed inside
each well. Biofilms were allowed to form on the slides at
37 °C for 48 h following which, the samples were fixed
in 4 % (v/v) glutaraldehyde in 0.05 M phosphate buffer
(pH 7.0) at 4 °C for 12 h. Subsequently, the samples
were washed three times in phosphate buffer, dehydrated
through a graded ethanol series, dried in a critical-point
drying apparatus with liquid carbon dioxide, sputter coated
with gold and viewed using a LEO 1450VP (Electron
Microscopy Unit, Universiti Kebangsaan Malaysia).
Motility assays
Motility assays on solid agar were performed using B.
pseudomallei that had been cultured on Ashdown’s agar
at 37 °C in air for 48 h. Swim agar plates were composed
of 1 % tryptone, 0.5 % NaCl, 0.3 % agar whilst 0.5 % agar
plates were used to observe swarming. Bacterial cells
from an isolated colony was point inoculated into the
centre of a swim plate or on the surface of a swarm plate
using a sterile toothpick. Plates were incubated at 37 °C
in air for up to 72 h, after which the widest colony diam-
eter was measured represented by the circular turbid
zone (swim plates) or migratory growth pattern (swarm
plates) formed by the bacterial cells migrating away from
the point of inoculation [59].
C. elegans survival assays
The wild type C. elegans N2 strain used in this study
was obtained from the Tan Laboratory at Stanford Uni-
versity. The nematode was propagated on nematode
growth medium (NGM) and fed on the normal food
source, E. coli OP50 [60], at 16 °C.
C. elegans survival assays were performed as previously
described [61, 62] with minor modifications. B. pseudo-
mallei isolates (UM1, UM2, UM5 and UM6), B. thailan-
densis ATCC 700388 and E. coli OP50 were grown
overnight in 1 mL Brain Heart Infusion (BHI) broth or
LB broth at 37 °C. Ten μL of an overnight culture was
spread over a small area on 3.5-cm NGM plates and in-
cubated at 37 °C for 24 h. Plates were then allowed to
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equilibrate to room temperature for 12–24 h before use.
Glp worms were prepared as previously described [63]
and thirty age-matched Glp worms were transferred to
NGM plates seeded with individual Burkholderia isolates
and incubated at 25 °C. The number of live and dead
worms was scored at 4–6 h intervals. For all the assays,
E. coli OP50 was used in place of B. pseudomallei as the
negative control.
Ethics statement
All animal experiments were performed in accordance with
the Universiti Kebangsaan Malaysia animal ethics guideline
formulated in accordance to the guidelines of the National
Health and Medical Research Council of Australia. The ex-
periments were approved by the Universiti Kebangsaan
Malaysia Animal Ethics Committee (UKMAEC) under ap-
proval number FST/SBB/2010/SHEILA/24-AUGUST/320.
Mice survival assay
Female BALB/c mice, aged 8–10 weeks old, were obtained
from the Animal House Facility, Universiti Kebangsaan
Malaysia (UKM). Mice were maintained under specific-
pathogen-free conditions in a positive pressure environ-
ment at 20–25 °C, subjected to a 12 h light/dark cycle and
fed with a protein-enriched diet and water ad libitum. B.
pseudomallei isolates, UM1, UM2, UM5 and UM6 were
cultured as described previously. Mice were challenged in-
traperitoneally with ~1 × 106 CFU of B. pseudomallei
UM1 or UM6 and their survival was monitored. The lung,
liver and spleen were aseptically removed from mice that
succumbed to disease and individually homogenized in
5 mL of PBS. Organ homogenates were serially diluted
with PBS and the dilution was plated on Ashdown agar.
The bacterial load in each organ was determined as CFU
per organ. The remaining homogenates were centrifuged
and supernatants were used for cytokine analysis. Sta-
tistical analysis on the difference in organ bacterial load
was performed using the Mann–Whitney test within the
GraphPad Prism version 4.0 (GraphPad Software) soft-
ware package.
Measurement of proinflammatory cytokine levels
Mouse cytokine Multi-Analyte ELISArray Kit (Qiagen)
was used to measure levels of IL-1α, IL-1β, IL-2, IL-4,
IL-6, IL-10, IL-12, IL-17A, Interferon-γ (IFN-γ), Tumour
necrosis factor-α (TNF-α), Granulocyte-Colony Stimu-
lating Factor (G-CSF) and Granulocyte-Macrophage
Colony Stimulating Factor (GM-CSF) in the organ hom-
ogenate supernatants from mice infected with B. pseudo-
mallei strains UM1 or UM6. The arrays were performed
according to the manufacturer’s instructions. The ab-
sorbance was measured at 450 nm with an automated
Sunrise ELISA reader (Tecan, Switzerland).
Additional files
Additional file 1: Biofilm production by clinical isolates of B.
pseudomallei. Diagram shows the relative comparison of biofilm
formation by 87 B. pseudomallei clinical isolates (black bars). B.
thailandensis ATCC 700388 was used as the reference for calculation of
biofilm-forming capacity (red bar). Biofilm formation of P. aeruginosa
ATCC 27852 (blue bar) and three other B. pseudomallei reference strains
(K96243, ATCC 23343 and NCTC 13178) (yellow bars) were also included.
Additional file 2: Analysis of transcriptome sequencing reads
mapped to the K96243 genome.
Additional file 3: Summary of significant differentially expressed
genes. Classification of (A) biological function and (B) predicted cellular
localization as analysed by PSORT. Pie charts indicate the percentage of
up- and down-regulated genes that were significantly regulated in UM6
(high biofilm producer) compared to UM1 (low biofilm producer). Genes
were divided into functional categories based on Comprehensive
Microbial Resources (CMR) annotations.
Additional file 4: Transcriptional changes of genes involved in B.
pseudomallei biofilm formation. Shown is the expression profile for
significantly regulated genes of UM6 (high biofilm producer) compared
to UM1 (low biofilm producer). The genes transcripts are expressed as
fragments per kilobase of transcript per million mapped reads (FPKM).
Additional file 5: qRT-PCR analysis of genes found to be
differentially regulated by RNASeq.
Additional file 6: Two putative B. pseudomallei sensor kinases,
BPSL2025 and BPSL1634 are members of RcsC. The amino sequences
of two putative B. pseudomallei sensor kinases, BPSL2026 (YP_108622.1)
and BPSL1634 (YP_108248.1) were aligned with E. coli sensor protein
RcsC (NP_416722.2) using ClustalW. Conserved residues are highlighted
in red and the conserved domains are underlined.
Additional file 7: B. pseudomallei hypothetical protein BPSL0617 is
a member of the CRP/FNR family protein. The amino sequence of
BPSL0617 (YP_107246.1) was aligned with BCAM1349 (YP_002233964.1)
using ClustalW. Conserved residues are highlighted in red.
Additional file 8: B. pseudomallei genes clusters that contribute to
biofilm development. Genomic organization of the B. pseudomallei
gene clusters that contribute to biofilm development as identified
in this study. Arrows indicate the direction of transcription and colours
depict the expression profile. Up and down-regulated genes are coloured
in red and green, respectively.
Additional file 9: Details and biofilm formation index of B.
pseudomallei clinical isolates and reference bacterial strains used in
this study.
Additional file 10: Primer sequences used for quantitative RT-PCR.
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